ORLANDO, Fla., Nov. 13, 2025 /PRNewswire/ -- Ingenus Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of Conjugated Estrogens Tablets, USP, ...
The generic product is now available nationwide in strengths of 0.3mg, 0.45mg, 0.625mg, 0.9mg, and 1.25mg. The Food and Drug Administration (FDA) has approved the first generic version of Premarin ® ...
NEW YORK--(BUSINESS WIRE)--In connection with the New York Times’ recent coverage of hormone therapy 1, Pfizer Inc. today released important facts and context to respond to the newspaper’s account.
Collegeville, Pa., June 20, 2007 -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), provides comment on the Women’s Health Initiative (WHI) Coronary Artery Calcium Study published today in The ...
NEW YORK--(BUSINESS WIRE)--In connection with the New York Times' recent coverage of hormone therapy1, Pfizer Inc. today released important facts and context to respond to the newspaper's account.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results